Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
Clinical characteristics of study participantsVariablesMen(n = 447)Women(n = 231)Sarcopenia(n = 84)Non-sarcopenia(n = 363)pSarcopenia(n = 34)Non-sarcopenia(n = 197)pAge(y)63.71 ± 14.5154.53 ± 12.770.0364.59 ± 10.6961.31 ± 11.790.12Education level(%)0.390.17Junior high school or below76.2%(64)71.6%(260)97.1%(33)89.8%(177)High school and above23.8%(20)28.4%(103)2.9%(1)10.2%(20)Drinking (%)52.4%(44)55.6%(202)0.582.9%(1)5.1%(10)0.58Smoking (%)67.9%(57)58.4%(212)0.112.9%(1)0.5%(1)0.15Stroke (%)20.2%(17)7.7%(28)< 0.0111.8%(4)12.2%(24)0.94Coronary Heart Disease (%)19.0%(16)7.2%(26)< 0.012.9%(1)7.6%(15)0.32BMD(SD)L1-L4-0.71 ± 1.76-0.33 ± 1.430.18-1.88 ± 1.36-1.34 ± 1.540.05femoral neck-1.67 ± 1.08-0.79 ± 1.110.95-2.02 ± 1.06-1.36 ± 1.15< 0.01Hip-1.31 ± 1.05-0.57 ± 1.030.93-1.73 ± 1.19-0.87 ± 1.26< 0.01BMI21.38 ± 2.8324.33 ± 3.260.2020.45 ± 2.8923.72 ± 3.13< 0.01WC (cm)85.96 ± 9.7991.66 ± 8.990.3284.10 ± 8.3490.16 ± 9.33< 0.01HC (cm)90.00 ± 7.9395.22 ± 6.16< 0.0190.24 ± 5.7394.19 ± 7.09< 0.01SBP (mmHg)142.28 ± 21.96131.29 ± 18.720.05141.44 ± 22.76136.56 ± 19.690.24DBP(mmHg)78.53 ± 12.3176.91 ± 11.290.2277.33 ± 10.0675.69 ± 9.470.40HbA1c(%)9.49 ± 2.559.74 ± 2.390.999.29 ± 21.509.27 ± 2.200.9625(OH)D (nmol/L)49.89 ± 20.9359.42 ± 21.190.9451.92 ± 19.7056.19 ± 19.350.25Estradiol(pmol/L)201.39 ± 89.96170.43 ± 66.34< 0.01143.18 ± 148.75141.92 ± 127.770.96Testosterone(nmol/L)10.14 ± 4.9510.98 ± 4.340.350.90 ± 0.591.01 ± 0.970.54IGF-1 (ng/mL)165.78 ± 116.71163.36 ± 55.840.01153.90 ± 51.01129.42 ± 56.570.21ASM (kg)17.59 ± 1.9823.21 ± 3.07< 0.0112.15 ± 1.2916.51 ± 2.18< 0.01SMI (kg/m2)6.36 ± 0.558.09 ± 0.94< 0.014.93 ± 0.416.67 ± 0.77< 0.01Grip(kg)22.62 ± 7.4136.06 ± 7.980.3214.40 ± 5.1420.60 ± 5.45< 0.01Gait speed(m/s)0.81 ± 0.241.08 ± 0.200.120.82 ± 0.170.92 ± 0.190.02Osteopenia (%)39.5%(32)32.2%(112)0.2037.5%(12)36.5%(69)0.91Osteoporosis (%)30.9%(25)8.6%(30)< 0.0146.9%(15)33.9%(64)0.15SBP, systolic blood pressure; DBP, diastolic blood pressure; WC, waist circumference; BMI, body mass index; WC, waist circumference; HC, hip circumference; BMD, bone mineral density; ASM, appendicular skeletal muscle mass; SMI, skeletal muscle mass index; HbA1c, glycosylated hemoglobin; 25(OH)D, 25-hydroxyvitamin D; IGF-1, insulin-like growth factor-1; The differences between groups were compared using the t-test, and categorical data, using χ2 test.
Source: Results. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Study design awaiting verification.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.
Meta-analysis unclear · Blinding unclear / not reported · Research setting awaiting verification
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Association of sarcopenia with osteoporosis in Chinese patients with type 2 diabetes
Study design awaiting verification · BMC Musculoskeletal Disorders · 2024
Original publication title
Association of sarcopenia with osteoporosis in Chinese patients with type 2 diabetes
© The Author(s) 2024
Original publication · Publisher record · CC BY 4.0 · CC0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What background does the paper provide?
People with type 2 diabetes mellitus (T2DM) present a higher tendency to develop sarcopenia and osteoporosis compared with the normal population. Currently, osteoporosis screening has been frequently performed among T2DM patients, but sarcopenia screening is relatively less, and the association between the two diseases remains unclear. Herein, this study aims to determine the association between sarcopenia and osteoporosis in Chinese T2DM patients.
Source: BackgroundAbstract: What methods does the paper describe?
This was a retrospective study of 678 patients with T2DM in the First Affiliated Hospital of Wenzhou Medical University. The bone mineral density (BMD) and muscle mass were measured by using dual-energy X-ray absorptiometry scanning. The diagnostic criteria of sarcopenia referred to the consensus by the Asia Working Group for Sarcopenia (AWGS).
Source: MethodsAbstract: Result
Among T2DM patients, the proportion of the sarcopenia population complicated with osteoporosis was higher than that of the non-sarcopenia (30.9% vs. 8.6% in men and 46.9% vs. 33.9% in women), but only significantly in men. The BMD of the hip and femoral neck was positively correlated with skeletal muscle mass index (SMI), grip strength, and gait speed (P < 0.01). After adjusting all covariates, the association between sarcopenia and BMD showed odds ratios of 0.43 (95% CI:0.28 to 0.66) for the femoral neck and 0.49 (95% CI:0.32 to 0.73) for the hip.
Source: ResultAbstract: Conclusions
The BMD of the hip and femoral neck in T2DM patients is related to sarcopenia-related indicators and represents an independent protective factor for sarcopenia. To reduce the risk of falls, fractures, and weakness, it is necessary to take sarcopenia assessment in people with T2DM and osteopenia/osteoporosis.
Source: ConclusionsAuthors’ abstract
Background
People with type 2 diabetes mellitus (T2DM) present a higher tendency to develop sarcopenia and osteoporosis compared with the normal population. Currently, osteoporosis screening has been frequently performed among T2DM patients, but sarcopenia screening is relatively less, and the association between the two diseases remains unclear. Herein, this study aims to determine the association between sarcopenia and osteoporosis in Chinese T2DM patients.
Methods
This was a retrospective study of 678 patients with T2DM in the First Affiliated Hospital of Wenzhou Medical University. The bone mineral density (BMD) and muscle mass were measured by using dual-energy X-ray absorptiometry scanning. The diagnostic criteria of sarcopenia referred to the consensus by the Asia Working Group for Sarcopenia (AWGS).
Result
Among T2DM patients, the proportion of the sarcopenia population complicated with osteoporosis was higher than that of the non-sarcopenia (30.9% vs. 8.6% in men and 46.9% vs. 33.9% in women), but only significantly in men. The BMD of the hip and femoral neck was positively correlated with skeletal muscle mass index (SMI), grip strength, and gait speed (P < 0.01). After adjusting all covariates, the association between sarcopenia and BMD showed odds ratios of 0.43 (95% CI:0.28 to 0.66) for the femoral neck and 0.49 (95% CI:0.32 to 0.73) for the hip.
Conclusions
The BMD of the hip and femoral neck in T2DM patients is related to sarcopenia-related indicators and represents an independent protective factor for sarcopenia. To reduce the risk of falls, fractures, and weakness, it is necessary to take sarcopenia assessment in people with T2DM and osteopenia/osteoporosis.
Publication and source details
Original title: Association of sarcopenia with osteoporosis in Chinese patients with type 2 diabetes
Ke Xu; Xiaozhen Feng; Zeru Xu; Yang Pan; Ping Zhang; Hong Zhu
BMC Musculoskeletal Disorders · 2024
© The Author(s) 2024https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-11T12:34:13.358769+00:00
DOI: 10.1186/s12891-024-07323-2 · PMC10956338